Stocks pare gains on report of Gilead antiviral drug trial flop
The Financial Times reports Gilead Sciences' coronavirus drug failed its first randomized clinical trial. Yahoo Finance’s Anjalee Khemlani joins Seana Smith to discuss. Video Transcript SEANA SMITH: We have stocks well off their highs today after a new report says that a potential Gilead coronav...